Unison Advisors LLC Gilead Sciences, Inc. Transaction History

Unison Advisors LLC

$828 Million
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 05, 2023	BUY	$73.94 - $80.67 $15,897 - $17,344	215 Added 0.97%	22,395 $1.68 Million
Q2 2023 Jul 28, 2023	BUY	$76.01 - $86.7 $15,049 - $17,166	198 Added 0.9%	22,180 $1.71 Million
Q1 2023 Apr 14, 2023	BUY	$77.31 - $88.08 $17,317 - $19,729	224 Added 1.03%	21,982 $1.82 Million
Q4 2022 Jan 23, 2023	BUY	$62.32 - $89.47 $15,829 - $22,725	254 Added 1.18%	21,758 $0
Q3 2022 Oct 13, 2022	BUY	$59.54 - $68.01 $14,646 - $16,730	246 Added 1.16%	21,504 $1.33 Million
Q2 2022 Jul 13, 2022	BUY	$57.72 - $65.01 $14,718 - $16,577	255 Added 1.21%	21,258 $1.31 Million
Q1 2022 Apr 13, 2022	BUY	$57.92 - $72.58 $11,699 - $14,661	202 Added 0.97%	21,003 $1.25 Million
Q4 2021 Jan 27, 2022	BUY	$64.88 - $73.64 $17,258 - $19,588	266 Added 1.3%	20,801 $1.51 Million
Q3 2021 Oct 20, 2021	SELL	$67.69 - $73.03 $342,172 - $369,166	-5,055 Reduced 19.75%	20,535 $1.44 Million
Q2 2021 Jul 28, 2021	BUY	$63.47 - $69.35 $154,930 - $169,283	2,441 Added 10.54%	25,590 $1.76 Million
Q1 2021 Apr 20, 2021	BUY	$60.0 - $68.46 $14,760 - $16,841	246 Added 1.07%	23,149 $1.5 Million
Q4 2020 Jan 19, 2021	BUY	$56.65 - $64.55 $13,935 - $15,879	246 Added 1.09%	22,903 $1.33 Million
Q3 2020 Oct 27, 2020	BUY	$62.1 - $78.08 $11,799 - $14,835	190 Added 0.85%	22,657 $1.43 Million
Q2 2020 Jul 09, 2020	BUY	$72.34 - $84.0 $285,598 - $331,632	3,948 Added 21.32%	22,467 $1.73 Million
Q1 2020 Apr 29, 2020	BUY	$62.63 - $80.22 $11,085 - $14,198	177 Added 0.96%	18,519 $1.39 Million
Q4 2019 Jan 08, 2020	BUY	$61.62 - $67.78 $10,906 - $11,997	177 Added 0.97%	18,342 $1.19 Million
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $10,564 - $11,661	169 Added 0.94%	18,165 $1.15 Million
Q2 2019 Jul 11, 2019	BUY	$61.87 - $69.38 $10,517 - $11,794	170 Added 0.95%	17,996 $1.22 Million
Q1 2019 Apr 18, 2019	BUY	$62.53 - $70.05 $9,191 - $10,297	147 Added 0.83%	17,826 $1.16 Million
Q4 2018 Feb 05, 2019	BUY	$60.54 - $79.0 $7,688 - $10,033	127 Added 0.72%	17,679 $1.11 Million
Q3 2018 Nov 02, 2018	BUY	$71.28 - $78.92 $9,123 - $10,101	128 Added 0.73%	17,552 $1.36 Million
Q2 2018 Jul 19, 2018	BUY	$64.88 - $75.68 $8,693 - $10,141	134 Added 0.78%	17,424 $1.23 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $8,303 - $10,123	114 Added 0.66%	17,290 $1.3 Million
Q4 2017 Jan 24, 2018	BUY	$71.15 - $83.52 $1.22 Million - $1.43 Million	17,176	17,176 $1.23 Million

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

Black Rock Inc. New York, NY

121M
Shares

$10.6 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.2 Billion
0.15% of portfolio
Capital World Investors Los Angeles, CA

76.2M
Shares

$6.72 Billion
0.88% of portfolio
Capital Research Global Investors Los Angeles, CA

60.4M
Shares

$5.32 Billion
0.94% of portfolio
State Street Corp Boston, MA

59.3M
Shares

$5.23 Billion
0.18% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Unison Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Unison Advisors LLC with notifications on news.

Account